BARROW ROBERT (Chief Executive Officer) received a stock award from DEFINIUM THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 8/12/2026ACC: 0001193125-26-345839
DirectorOfficer· Chief Executive Officer
Since Jan 2022
+375K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
375K acquired
Non-Derivative Transactions1
Common Shares
Direct
Shares
+375K
Price / share
—
Trade value
—
% of position
34.1%
8/12/2026
1.10M→1.47M
Total
Net shares
+375K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 8/12/2026 | A · Award | +375K | — | — | 34.1% | 1.10M | 1.47M |
| Total | +375K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported